|Bid||463.70 x 0|
|Ask||472.85 x 0|
|Day's range||460.30 - 460.30|
|52-week range||316.20 - 505.60|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Zylorion Health Inc., ("Zylorion" or the "Company"), a precision mental health care and psychedelic therapy focused innovator, is pleased to announce the addition of Mr. Jeroen Tas to the Company's Board of Directors, and the addition of Dr. Ted Goldstein to the Company's Digital Health Advisory Committee.
BETHESDA, Md. & INDIANAPOLIS, August 02, 2022--Elevance Health, (NYSE: ELV), one of the nation’s leading health companies, and Aledade, an innovative primary care physician enablement company, today announced a partnership that will help enhance the consumer experience and health outcomes for those seeking services from independent primary care practices. The partnership centers on assisting independent primary care physicians across the country transition to value-based care, which is proven to
WASHINGTON, July 20, 2022--Inconsistent and incomplete data about health plan enrollees’ races and ethnicities makes it difficult to track and evaluate efforts to reduce health inequities, according to new research conducted by the Urban Institute, the American Benefits Council and Deloitte’s Health Equity Institute, and funded by Elevance Health.